Publication Cover
Journal of Dual Diagnosis
research and practice in substance abuse comorbidity
Volume 9, 2013 - Issue 4
912
Views
3
CrossRef citations to date
0
Altmetric
Psychopharmacology & Neurobiology: Article

Mecamylamine for Treatment of People With Dual Diagnoses of Depression and Alcohol Dependence

, , , , , , , , & show all
Pages 301-310 | Published online: 28 Oct 2013

REFERENCES

  • Altintoprak , A. E. , Zorlu , N. , Coskunol , H. , Akdeniz , F. and Kitapcioglu , G. 2008 . Effectiveness and tolerability of mirtazapine and amitriptyline in alcoholic patients with co-morbid depressive disorder: A randomized, double-blind study . Human Psychopharmacology , 23 ( 4 ) : 313 – 319 . doi: 10.1002/hup.935
  • Anda , R. F. , Williamson , D. F. and Escobedo , L. G. 1990 . Depression and the dynamics of smoking . JAMA: The Journal of the American Medical Association , 264 : 1541 – 1545 . doi: 10.1001/jama.1990.03450120053028
  • Anton , R. F. , Moak , D. H. and Latham , P. K. 1996 . The Obsessive Compulsive Drinking Scale: A new method of assessing outcome in alcoholism treatment studies . Archives of General Psychiatry , 53 ( 3 ) : 225 – 231 . [published erratum appears in Arch Gen Psychiatry 1996 Jul; 53(7): 576] doi: 10.1001/archpsyc.1996.01830030047008
  • Blomqvist , O. , Hernandez-Avila , C. A. , Van Kirk , J. , Rose , J. E. and Kranzler , H. R. 2002 . Mecamylamine modifies the pharmacokinetics and reinforcing effects of alcohol . Alcoholism: Clinical & Experimental Research , 26 ( 3 ) : 326 – 331 . doi: 10.1111/j.1530–0277.2002.tb02541.x
  • Boden , J. M. and Fergusson , D. M. 2011 . Alcohol and depression . Addiction , 106 ( 5 ) : 906 – 914 . doi: 10.1111/j.1360-0443.2010.03351.x
  • Breese , C. R. , Lee , M. J. , Adams , C. E. , Sullivan , B. , Logel , J. , Gillen , K. M. and Leonard , S. 2000 . Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia . Neuropsychopharmacology , 23 ( 4 ) : 351 – 364 . doi: 10.1016/S0893-133X(00)00121-4
  • CDC . 2005 . Cigarette smoking among adults–United States, 2004 . MMWR (Morbidity and Mortality Weekly) , 54 ( 44 ) : 1121 – 1148 . www.cdc.gov
  • Chi , H. and de Wit , H. 2003 . Mecamylamine attenuates the subjective stimulant-like effects of alcohol in social drinkers . Alcoholism: Clinical & Experimental Research , 27 ( 5 ) : 780 – 786 . doi: 10.1097/01.ALC.0000065435.12068.24
  • Cornelius , J. R. , Salloum , I. M. , Ehler , J. G. , Jarrett , P. J. , Cornelius , M. D. , Perel , J. M. and Black , A. 1997 . Fluoxetine in depressed alcoholics. A double-blind, placebo-controlled trial [see comments] . Archives of General Psychiatry , 54 ( 8 ) : 700 – 705 . doi: 10.1001/archpsyc.1997.01830200024004
  • Covey , L. S. , Glassman , A. H. and Stetner , F. 1997 . Major depression following smoking cessation . American Journal of Psychiatry , 154 ( 2 ) : 263 – 265 .
  • Dani , J. A. and Harris , R. A. 2005 . Nicotine addiction and comorbidity with alcohol abuse and mental illness . Nature Neuroscience , 8 ( 11 ) : 1465 – 1470 . doi: 10.1038/nn1580
  • Davis , L. , Uezato , A. , Newell , J. and Frazier , E. 2008 . Major depression and comorbid substance use disorders . Current Opinion in Psychiatry , 21 ( 1 ) : 14 – 18 . doi: 10.1097/YCO.0b013e3282f32408
  • Driessen , M. , Meier , S. , Hill , A. , Wetterling , T. , Lange , W. and Junghanns , K. 2001 . The course of anxiety, depression and drinking behaviours after completed detoxification in alcoholics with and without comorbid anxiety and depressive disorders . Alcohol and Alcoholism , 36 ( 3 ) : 249 – 255 . doi: 10.1093/alcalc/36.3.249
  • Dunbar , D. C. , Kuchibhatla , R. and Kumar , R. Mecamylamine in the treatment of depressed patients who were inadequate responders to citalopram first-line therapy; A double-blind placebo controlled add-on study . Presented at the 2007 Summer Meeting of the British Association for Psychopharmacology, Harrogate International Centre , UK July
  • Epstein , J. F. , Induni , M. and Wilson , T. 2009 . Patterns of clinically significant symptoms of depression among heavy users of alcohol and cigarettes . Preventing Chronic Disease , 6 ( 1 ) www.cdc.gov/pcd/issues/2009/jan/08_0009.htm
  • Freedman , R. 2007 . Exacerbation of schizophrenia by varenicline . American Journal of Psychiatry , 164 ( 8 ) : 1269 doi: 10.1176/ appi.ajp.2007.07030388r
  • George , T. P. , Sacco , K. A. , Vessicchio , J. C. , Weinberger , A. H. and Shytle , R. D. 2008 . Nicotinic antagonist augmentation of selective serotonin reuptake inhibitor-refractory major depressive disorder: A preliminary study . Journal of Clinical Psychopharmacology , 28 ( 3 ) : 340 – 344 . doi: 10.1097/JCP.0b013e318172b49e
  • Gianoli , M. O. and Petrakis , I. L. 2013 . Pharmacotherapy for alcohol dependence and comorbid depression . Current Psychiatry , 12 ( 1 ) : 25 – 33 .
  • Glassman , A. H. , Helzer , J. E. , Covey , L. S. , Cottler , L. B. , Stetner , F. , Tipp , J. E. and Johnson , J. 1990 . Smoking, smoking cessation, and major depression[see comment] . JAMA: The Journal of the American Medical Association , 264 ( 12 ) : 1546 – 1549 . doi: 10.1001/jama.1990.03450120058029
  • Glover , E. D. , Laflin , M. T. , Schuh , K. J. , Schuh , L. M. , Nides , M. , Christen , A. G. and Strnad , J. V. 2007 . A randomized, controlled trial to assess the efficacy and safety of a transdermal delivery system of nicotine/mecamylamine in cigarette smokers . Addiction , 102 ( 5 ) : 795 – 802 . doi: 10.1111/j.1360-0443.2007.01763.x
  • Gonzales , D. , Rennard , S. I. and Nides , M. 2006 . Varenicline an α4β2 nicotinic acetylcholine receptor partial agonist, vs. sustained-release bupropion and placebo for smoking cessation: A randomized controlled trial . JAMA: The Journal of the American Medical Association , 296 ( 1 ) : 47 – 55 . doi: 10.1001/jama.296.1.47
  • Grant , B. F. , Stinson , F. S. , Dawson , D. A. , Chou , P. , Dufour , M. C. , Compton , W. and Kaplan , K. 2004 . Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) . Archives of General Psychiatry , 61 ( 8 ) : 807 – 816 . doi: 10.1001/archpsyc.61.8.807
  • Gulliver , S. B. , Kalman , D. , Rohsenow , D. J. , Colby , S. M. , Eaton , C. A. and Monti , P. M. 2000 . Smoking and drinking among alcoholics in treatment: Cross-sectional and longitudinal relationships . Journal of Studies on Alcohol , 61 ( 1 ) : 157 – 163 .
  • Gulliver , S. B. , Rohsenow , D. J. , Colby , S. M. , Dey , A. N. , Abrams , D. B. , Niaura , R. S. and Monti , P. M. 1995 . Interrelationship of smoking and alcohol dependence, use and urges to use . Journal of Studies on Alcohol , 56 : 202 – 206 .
  • Hamilton , M. 1960 . A rating scale for depression . Journal of Neurology, Neurosurgery, and Psychiatry , 23 : 56 – 62 . http://www.ncbi.nlm.nih.gov/pmc/articles/PMC495331/
  • Hobbs , J. D. J. , Kushner , M. G. , Lee , S. S. , Reardon , S. M. and Maurer , E. W. 2011 . Meta-analysis of supplemental treatment for depressive and anxiety disorders in patients being treated for alcohol dependence . The American Journal on Addictions , 20 : 319 – 329 . doi: 10.1111/j.1521-0391.2011.00140.x
  • Houtsmuller , E. , Brasser , S. and Foster , K. Effects of mecamylamine on alcohol effects, craving and self-administration . Paper presented at the 28th Annual Meeting of the Research Society on Alcoholism , Santa Barbara , , CA June
  • Hughes , J. R. 2007 . Depression during tobacco abstinence . Nicotine & Tobacco Research , 9 ( 4 ) : 443 – 446 . doi: 10.1080/14622200701243185
  • Jané-Llopis , E. and Maytsina , I. 2006 . Mental health and alcohol, drugs and tobacco: A review of the comorbidity between mental disorders and the use of alcohol, tobacco and illicit drugs . Drug and Alcohol Review , 25 ( 6 ) : 515 – 536 . doi: 10.1080/09595230600944461
  • Jorenby , J. T. , Hays , J. T. , Rigotti , N. A. , Azoulay , S. , Watsky , E. J. , Williams , K. E. and the Varenicline Phase 3 Study Group . 2006 . Efficacy of varenicline, an nicotinic α4β2 acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: A randomized controlled trial . JAMA: The Journal of the American Medical Association , 296 ( 1 ) : 56 – 63 . doi: 10.1001/jama.296.1.56
  • Kalman , D. , Morissette , S. B. and George , T. P. 2005 . Co-morbidity of smoking in patients with psychiatric and substance use disorders . American Journal on Addictions , 14 ( 2 ) : 106 – 123 . doi: 10.1080/10550490590924 728
  • Kohen , I. and Kreman , N. 2007 . Varenicline-induced manic episode in a patient with bipolar disorder . American Journal of Psychiatry , 164 ( 8 ) : 1269 – 1270 . doi: 10.1176/appi.ajp.2007.07010173
  • Krystal , J. , Staley , J. , Mason , G. , Petrakis , I. , Kaufman , J. , Harris , R. and Lappalainen , J. 2006 . GABAA receptors and alcoholism: Intoxication, dependence, vulnerability, and treatment . Archives of General Psychiatry , 63 : 957 – 968 . doi: 10.1001/archpsyc.63.9.957
  • Lancaster , T. and Stead , L. F. 1998 . Mecamylamine (a nicotine antagonist) for smoking cessation . Cochrane Database of Systematic Reviews , 2 doi: 10.1002/14651858.CD001009
  • Levine , J. and Schooler , N. R. 1986 . SAFTEE: A technique for the systematic assessment of side effects in clinical trials . Psychopharmacology Bulletin , 22 ( 2 ) : 343 – 381 . http://www.ncbi.nlm.nih.gov/pubmed/3774930
  • Lof , E. , deBejzy , A. , Guterstam , J. , Hammarberg , A. , Franck , J. and Asanovska , G. A randomized, double-blind, placebo-controlled study of the effect of varenicline in the treatment of alcohol dependence . Paper presented at the Research Society on Alcoholism (RSA), 35th Annual RSA Scientific Meeting , San Francisco , , CA June
  • Mason , B. J. , Kocsis , J. H. , Ritvo , E. C. and Cutler , R. B. 1996 . A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression . JAMA: The Journal of the American Medical Association , 275 ( 10 ) : 761 – 767 . doi: 10.1001/jama.1996.03530340025025
  • Mason , G. F. , Petrakis , I. L. , deGraaf , R. A. , Gueorguieva , R. , Ruff , E. , Coric , V. and Krystal , J. H. 2006 . Cortical gamma-aminobutyric acid levels and the recovery from ethanol dependence: Preliminary evidence of modification by cigarette smoking . Biological Psychiatry , 59 : 85 – 93 . doi: 10.1016/j.biopsych.2005.06.009
  • Matthew , R. J. , Weinman , M. I. and Mirabi , M. 1981 . Physical symptoms of depression . British Journal of Psychiatry , 139 : 293 – 296 . doi: 10.1192/bjp.139.4.293
  • McGrath , P. J. , Nunes , E. V. , Stewart , J. W. , Goldman , D. , Agosti , V. , Ocepek-Welikson , K. and Quitkin , F. M. 1996 . Imipramine treatment of alcoholics with primary depression: A placebo-controlled clinical trial . Archives of General Psychiatry , 53 ( 3 ) : 232 – 240 . doi: 10.1001/archpsyc.1996.01830030054009
  • McKee , S. A. , Harrison , E. L. , O’Malley , S. S. , Krishnan-Sarin , S. , Shi , J. , Tetrault , J. M. and Balchunas , E. 2009 . Varenicline reduces alcohol self-administration in heavy-drinking smokers . Biological Psychiatry , 66 ( 2 ) : 185 – 190 . doi: 10.1016/j.biopsych.2009.01.029
  • Mineur , Y. S. and Picciotto , M. R. 2010 . Nicotine receptors and depression: Revisiting and revising the cholinergic hypothesis . Trends in Pharmacological Sciences , 31 ( 12 ) : 580 – 586 . doi: 10.1016/j.tips.2010.09.004
  • Moak , D. H. , Anton , R. F. , Latham , P. K. , Voronin , K. E. , Waid , R. L. and Durazo-Arvizu , R. 2003 . Sertraline and cognitive behavioral therapy for depressed alcoholics: Results of a placebo-controlled trial . Journal of Clinical Psychopharmacology , 23 ( 6 ) : 553 – 562 . doi: 10.1097/01.jcp.0000095346.32154.41
  • Moore , T. J. , Furberg , C. D. , Glenmullen , J. , Maltsberger , J. T. and Singh , S. 2011 . Suicidal behavior and depression in smoking cessation treatments . PLoS One , 6 ( 11 ) doi: 10.1371/journal.pone.0027016
  • Murphy , J. M. , Burke , J. D. Jr. , Monson , R. R. , Horton , N. J. , Laird , N. M. and Lesage , A. 2008 . A 40-year perspective on the prevalence of depression: The Stirling County study . Social Psychiatry & Psychiatric Epidemiology , 43 ( 8 ) : 594 – 601 . doi: 10.1001/archpsyc.57.3.209
  • Nemeth-Coslett , R. , Henningfield , J. E. , O’Keeffe , M. K. and Griffiths , R. R. 1986 . Effects of mecamylamine on human cigarette smoking and subjective ratings . Psychopharmacology , 88 ( 4 ) : 420 – 425 .
  • Nunes , E. V. and Levin , F. R. 2004 . Treatment of depression in patients with alcohol or other drug dependence: A meta-analysis . JAMA: The Journal of the American Medical Association , 291 ( 15 ) : 1887 – 1896 . doi: 10.1001/jama.291.15.1887
  • Nunes , E. V. , McGrath , P. J. , Quitkin , F. M. , Stewart , J. P. , Harrison , W. , Tricamo , E. and Ocepek-Welikson , K. 1993 . Imipramine treatment of alcoholism with comorbid depression . American Journal of Psychiatry , 150 ( 6 ) : 963 – 965 .
  • Patterson , F. , Jepson , C. , Strasser , A. A. , Loughead , J. , Perkins , K. A. , Gur , R. C. and Lerman , C. 2009 . Varenicline improves mood and cognition during smoking abstinence . Biological Psychiatry , 65 ( 2 ) : 144 – 149 . doi: 10.1016/j.biopsych.2008.08.028
  • Philip , N. S. , Carpenter , L. L. , Tyrka , A. R. and Price , L. H. 2010 . Nicotinic acetylcholine receptors and depression: A review of the preclinical and clinical literature . Psychopharmacology , 212 ( 1 ) : 1 – 12 . doi: 10.1007/s00213-010-1932-6
  • Philip , N. S. , Carpenter , L. L. , Tyrka , A. R. and Price , L. H. 2012 . The nicotinic acetylcholine receptor as a target for antidepressant drug development . The Scientific World Journal, 2012 , doi: 10.1100/2012/104105
  • Pomerleau , C. S. , Pomerleau , O. F. and Majchrzak , M. J. 1987 . Mecamylamine pretreatment increases subsequent nicotine self-administration as indicated by changes in plasma nicotine level . Psychopharmacology , 91 ( 3 ) : 391 – 393 . doi: 10.1007/BF00518198
  • Popkin , M. K. 2008 . Exacerbation of recurrent depression as a result of treatment with varenicline . American Journal of Psychiatry , 165 ( 6 ) : 774 doi: 10.1176/appi.ajp.2008.07111735
  • Rose , J. E. , Behm , F. M. and Levin , E. D. 1993 . The role of nicotine dose and sensory cues in the regulation of smoke intake . Pharmacology Biochemistry and Behavior , 44 ( 4 ) : 891 – 900 . doi: 10.1016/0091-3057(93)90021-K
  • Rose , J. E. , Behm , F. M. and Westman , E. C. 1998 . Nicotine-mecamylamine treatment for smoking cessation: The role of pre-cessation therapy . Experimental & Clinical Psychopharmacology , 6 ( 3 ) : 331 – 343 . doi: 10.1037/1064-1297.6.3.331
  • Rose , J. E. , Behm , F. M. , Westman , E. C. and Bates , J. E. 2003 . Mecamylamine acutely increases human intravenous nicotine self-administration . Pharmacology Biochemistry and Behavior , 76 ( 2 ) : 307 – 313 . doi: 10.1016/j.pbb.2003.08.011
  • Rose , J. E. , Behm , F. M. , Westman , E. C. , Levin , E. D. , Stein , R. M. and Ripka , G. V. 1994 . Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone . Clinical Pharmacology & Therapeutics , 56 ( 1 ) : 86 – 99 . doi: 10.1038/clpt.1994.105
  • Salin-Pascual , R. J. , Rosas , M. , Jimenez-Genchi , A. , Rivera-Meza , B. L. and Delgado-Parra , V. 1996 . Antidepressant effect of transdermal nicotine patches in nonsmoking patients with major depression . Journal of Clinical Psychiatry , 57 ( 9 ) : 387 – 389 .
  • Schuckit , M. A. 2006 . Comorbidity between substance use disorders and psychiatric conditions . Addiction , 101 ( s1 ) : 76 – 88 . doi: 10.1111/j.1360-0443.2006.01592.x
  • Shytle , R. D. , Penny , E. , Silver , A. A. , Goldman , J. and Sanberg , P. R. 2002 . Mecamylamine (Inversine): An old antihypertensive with new research directions . Journal of Human Hypertension , 16 ( 7 ) : 453 – 457 . doi: 10.1038/sj.jhh.1001416
  • Shytle , R. D. , Silver , A. A. and Sanberg , P. R. 2000 . Comorbid bipolar disorder in Tourette's syndrome responds to the nicotinic receptor antagonist mecamylamine (Inversine) . Biological Psychiatry , 48 ( 10 ) : 1028 – 1031 . doi: 10.1016/S0006-3223(00)00945–8
  • Shytle , R. D. , Silver , A. A. , Sheehan , K. H. , Sheehan , D. V. and Sanberg , P. R. 2002 . Neuronal nicotinic receptor inhibition for treating mood disorders: Preliminary controlled evidence with mecamylamine . Depression & Anxiety , 16 ( 3 ) : 89 – 92 . doi: 10.1002/da.10035
  • Skinner , H. A. and Horn , J. L. 1984 . Alcohol Dependence Scale (ADS): User's guide , Toronto , , Ontario : Addiction Research Foundation .
  • Sobell , L. C. and Sobell , M. B. 1992 . “ Timeline Follow-Back: A technique for assessing self-reported alcohol consumption ” . In Measuring alcohol consumption: Psychosoical and biological methods , Edited by: Litten , R. Z. and Allen , J. 41 – 72 . Totowa , , NJ : Humana Press .
  • Staley , J. , Krishnan-Sarin , S. , Cosgrove , K. , Krantzler , E. , Frohlich , E. , Perry , E. and van Dyck , C. H. 2006 . Human tobacco smokers have higher levels of b2*nicotinic acetylcholine receptors during early abstinence . Journal of Neuroscience , 26 : 8707 – 8714 . doi: 10.1523/JNEUROSCI.0546-06.2006
  • Stolerman , I. P. , Goldfarb , T. , Fink , R. and Jarvik , M. E. 1973 . Influencing cigarette smoking with nicotine antagonists . Psychopharmacologia , 28 ( 3 ) : 247 – 259 .
  • Torrens , M. , Fonseca , F. , Mateu , G. and Farre , M. 2005 . Efficacy of antidepressants in substance use disorders with and without comorbid depression. A systematic review and meta-analysis . Drug & Alcohol Dependence , 78 ( 1 ) : 1 – 22 . doi: 10.1016/j.drugalcdep.2004.09.004
  • Yoon , S. J. , Pae , C. U. , Kim , D. J. , Namkoong , K. , Lee , E. , Oh , D. Y. and Lee , C. T. 2006 . Mirtazapine for patients with alcohol dependence and comorbid depressive disorders: A multicentre, open label study . Progress in Neuro Psychopharmacology & Biological Psychiatry , 30 ( 7 ) : 1196 – 1201 . doi: 10.1016/j.pnpbp.2006.02.018
  • Young , J. M. , Shytle , R. D. , Sanberg , P. R. and George , T. P. 2001 . Mecamylamine: New therapeutic uses and toxicity/risk profile . Clinical Therapeutics , 23 ( 4 ) : 532 – 565 . doi: 10.1016/S0149-2918(01)80059-X

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.